Open access
Sep 2026
The Potential Public Health Benefit of mRNA-1010 for Influenza Among Older Adults >=65 Years in the United States
Background/ObjectivesOlder adults are at high risk of influenza-related severe disease and complications. HD-IIV, currently recommended for adults [≥]65 years, is egg-based and may be subject to egg-adapted mutations. An mRNA-based vaccine for influenza, mRNA-1010, has been approved by the Food and Drug Administration....
K. Fust, E. Beck, M. Kohli et al.
· medRxiv · 0 citations